Carregant...

State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019

Abstract Experience in the use of CAR T cells to treat CLL is limited, but safety and efficacy data are encouraging, suggesting that it may be possible to use CAR T cells in populations of CLL patients with particularly unfavorable prognoses. Mechanisms intrinsic to the pathophysiology of CLL undoub...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Richard Lemal, Olivier Tournilhac
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019-08-01
Col·lecció:Journal for ImmunoTherapy of Cancer
Matèries:
CLL
Accés en línia:http://link.springer.com/article/10.1186/s40425-019-0686-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!